Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cibus, Inc. - Class A Common Stock (NQ: CBUS )

1.904 +0.034 (+1.82%)
Streaming Delayed Price Updated: 3:12 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 131,052
Open 1.890
Bid (Size) 1.900 (6)
Ask (Size) 1.920 (2)
Prev. Close 1.870
Today's Range 1.840 - 2.020
52wk Range 1.400 - 19.56
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
USDA-APHIS Designates Additional Cibus’ Disease Resistance Trait Products as Not Regulated
Designation confirms conventional regulation of Cibus traits in the U.S. as modernized regulatory policy for precision gene editing breeding technologies continues to advance globally 
From Cibus US LLC
Via GlobeNewswire
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
From Cibus US LLC
Via GlobeNewswire

Performance

YTD
-35.68%
-35.68%
1 Month
-13.45%
-13.45%
3 Month
-26.77%
-26.77%
6 Month
-46.96%
-46.96%
1 Year
-88.09%
-88.09%

More News

Read More
Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward
From Cibus US LLC
Via GlobeNewswire
What Analysts Are Saying About Cibus Stock
Via Benzinga
Analyst Ratings For Cibus
Via Benzinga
Earnings Scheduled For March 20, 2025
Via Benzinga
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
Cibus’ Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola
From Cibus US LLC
Via GlobeNewswire
Cibus Announces Leadership Change and CEO Succession Plan
From Cibus US LLC
Via GlobeNewswire
Cibus Announces Important Update to Rice Gene Editing Conversion Rates
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in the Sidoti Micro Cap Conference
From Cibus US LLC
Via GlobeNewswire
Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Sidoti Events, LLC's Virtual January Micro-Cap Conference
Via ACCESS Newswire
Cibus, Inc. Announces $22.6 Million Registered Direct Offering Priced Above Nasdaq’s Minimum Price in Accordance with Nasdaq Rules
From Cibus US LLC
Via GlobeNewswire
Cibus’ Agriculture Breeding Breakthroughs Create New Industry Paradigms for Development and Commercialization of Plant Traits
From Cibus US LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
From Cibus US LLC
Via GlobeNewswire
Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
From Cibus US LLC; Biographica
Via GlobeNewswire
Cibus to Participate in the 13th Annual Roth Technology Conference
From Cibus US LLC
Via GlobeNewswire
Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola
From Cibus US LLC
Via GlobeNewswire
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024
From Cibus US LLC
Via GlobeNewswire
Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola
From Cibus US LLC
Via GlobeNewswire
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities
From Cibus US LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.